Learning the ins and outs of the insurance process can be confusing at times. We’ll help point you in the right direction. Here’s what to expect when submitting for insurance coverage:
Once your child is diagnosed, their doctor will submit a medication authorization request to the insurance company before starting treatment. This process is known as prior authorization (PA). It is also referred to as precertification or prior approval. It involves satisfying criteria that insurance companies require to approve growth hormone (GH) medication.
Given the amount of information required to review and provide to insurance companies, prior authorization (PA) approval can take some time. Having your information organized will help you, the nurse, or the person performing the PA be more efficient. Some PAs need to be regularly reauthorized. Let your care team know if your authorization is close to ending. They can help you continue to get reauthorizations.
Now, your care team can begin coordinating medication shipments and start teaching you how to administer treatment.
If your request is denied, your healthcare team can begin the appeal, a process that may involve providing the following documents:
Many pharmaceutical companies offer co-pay support and other financial assistance to offset out of pocket costs. If you experience difficulties with authorization and appeals, see if the company that manufacturers your child’s GHD treatment offers an assistance program. Advocacy organizations are also available for help with insurance questions and appeals.
Your insurance company may choose a Specialty Pharmacy as their preferred pharmacy for GH treatment. Specialty Pharmacies are designed to provide faster access to the medicine your child needs. They may also offer support services for injection training and reimbursement.
You are about to leave the GHDinKids.com website and enter a website operated by an independent third party. The links to third-party websites contained on this site are provided solely for your convenience. Ascendis Pharma does not control the opinions, claims or comments contained on any third-party website linked to GHDinKids.com, and your activities at those websites will be governed by the policies and practices of those third parties.
You will now be redirected to learn more about a treatment option for children with GHD.